L, L., PM, S., A, R., G, N., AM, S., & V, K. S. (2023). Purine antimetabolites associated Pneumocystis jirovecii pneumonia. Pharmacoepidemiology and drug safety, 32(11), 1244. https://doi.org/10.1002/pds.5647
Chicago Style (17th ed.) CitationL, Lukose, Shantaram PM, Raj A, Nair G, Shaju AM, and K Subeesh V. "Purine Antimetabolites Associated Pneumocystis Jirovecii Pneumonia." Pharmacoepidemiology and Drug Safety 32, no. 11 (2023): 1244. https://doi.org/10.1002/pds.5647.
MLA (9th ed.) CitationL, Lukose, et al. "Purine Antimetabolites Associated Pneumocystis Jirovecii Pneumonia." Pharmacoepidemiology and Drug Safety, vol. 32, no. 11, 2023, p. 1244, https://doi.org/10.1002/pds.5647.
Warning: These citations may not always be 100% accurate.